AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
-4.44%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.08B
AUM Growth
+$1.08B
(-11%)
Cap. Flow
-$135M
Cap. Flow
% of AUM
-12.46%
Top 10 Holdings %
Top 10 Hldgs %
44.57%
Holding
85
New
18
Increased
20
Reduced
13
Closed
25
Top Buys
| 1 |
Vanda Pharmaceuticals
VNDA
|
$44.5M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$38.8M |
| 3 |
Lowe's Companies
LOW
|
$34.6M |
| 4 |
RH
RH
|
$25.9M |
| 5 |
United Therapeutics
UTHR
|
$25.3M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$52.1M |
| 2 |
VLRX
VALERITAS HOLDINGS INC
VLRX
|
$49.4M |
| 3 |
Pacira BioSciences
PCRX
|
$40.8M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$32.6M |
| 5 |
AutoZone
AZO
|
$28.7M |
Sector Composition
| 1 | Healthcare | 46.76% |
| 2 | Consumer Discretionary | 22.46% |
| 3 | Industrials | 8.21% |
| 4 | Consumer Staples | 7.21% |
| 5 | Technology | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Avalo Therapeutics
AVTX
$122M
| $100M | 6.32% | 18,429,285 +125,000 | +0.7% | +$680K |
|
2
Energizer
ENR
$1.88B
| $52.1M | 3.28% | 1,348,000 +52,000 | +4% | +$2.01M |
|
|
DFRG
3
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $48.8M | 3.07% | 6,125,000 +525,000 | +9% | +$4.18M |
|
|
4
Vanda Pharmaceuticals
VNDA
$279M
| $44.5M | 2.81% | +3,158,000 | New | +$44.5M |
|
5
Madrigal Pharmaceuticals
MDGL
$9.76B
| $42.8M | 2.7% | 408,000 -17,000 | -4% | -$1.78M |
|
6
Edgewell Personal Care
EPC
$1.12B
| $41.5M | 2.62% | 1,540,000 +568,000 | +58% | +$15.3M |
|
|
7
Regeneron Pharmaceuticals
REGN
$61.5B
| $38.8M | 2.45% | +124,000 | New | +$38.8M |
|
8
Burlington
BURL
$18.3B
| $38.1M | 2.4% | 224,000 +24,000 | +12% | +$4.08M |
|
|
AMAG
9
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $38M | 2.39% | 3,800,000 +484,000 | +15% | +$4.84M |
|
|
CELG
10
DELISTED
Celgene Corp
CELG
| $37M | 2.33% | 400,000 -192,000 | -32% | -$17.7M |
|
|
WBT
11
DELISTED
Welbilt, Inc.
WBT
| $36.6M | 2.31% | 2,192,000 +192,000 | +10% | +$3.21M |
|
|
12
Lowe's Companies
LOW
$145B
| $34.6M | 2.18% | +343,000 | New | +$34.6M |
|
13
Enanta Pharmaceuticals
ENTA
$180M
| $32.1M | 2.02% | 380,000 +8,000 | +2% | +$675K |
|
14
Assembly Biosciences
ASMB
$190M
| $27M | 1.7% | 2,000,000 +872,000 | +77% | +$11.8M |
|
|
15
RH
RH
$4.23B
| $25.9M | 1.63% | +224,000 | New | +$25.9M |
|
16
J.M. Smucker
SJM
$11.8B
| $25.8M | 1.63% | 224,000 +124,000 | +124% | +$14.3M |
|
17
Five Below
FIVE
$8B
| $25.6M | 1.61% | 213,000 +141,000 | +196% | +$16.9M |
|
18
Voyager Therapeutics
VYGR
$186M
| $25.5M | 1.61% | 936,000 -600,000 | -39% | -$16.3M |
|
|
19
United Therapeutics
UTHR
$13.8B
| $25.3M | 1.59% | +324,000 | New | +$25.3M |
|
20
Dropbox
DBX
$7.84B
| $23.8M | 1.5% | 950,000 +700,000 | +280% | +$17.5M |
|
21
Frontdoor
FTDR
$4.43B
| $21.8M | 1.37% | 500,000 -632,000 | -56% | -$27.5M |
|
|
ATRS
22
DELISTED
Antares Pharma, Inc.
ATRS
| $19.7M | 1.24% | 6,000,000 -4,300,000 | -42% | -$14.1M |
|
|
DPLO
23
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $19.5M | 1.23% | 3,200,000 +200,000 | +7% | +$1.22M |
|
24
Incyte
INCY
$16.5B
| $19.4M | 1.22% | +228,000 | New | +$19.4M |
|
25
Catalyst Pharmaceutical
CPRX
$2.52B
| $19.2M | 1.21% | 5,000,000 +3,480,000 | +229% | +$13.4M |
|